Profile
Corporate information
Registration country
Registration country
Investment activity status
Active investor
Company type
A biopharmaceutical company focused on bringing innovative medicines to patients with central nervous system disorders of high unmet medical need.Funding
Funding rounds
Acquisition USD 3,500,000,000
USD 3,500,000,000 (1 Dec 2014) at USD 3,500,000,000 valuation.
Investor | Profile | Country | Notes | |
---|---|---|---|---|
Otsuka Pharmaceutical | USD 3,500,000,000 (USD 3,500,000,000). Initial investment. Led the round. |
(1 Jun 2012)
Investor | Profile | Country | Notes | |
---|---|---|---|---|
Oxford Finance LLC | Provider of capital exclusively to life sciences and healthcare services companies worldwide. | United States | Initial investment. Round participant. |
(1 Apr 2008)
Investor | Profile | Country | Notes | |
---|---|---|---|---|
Clarus Ventures LLC | Life sciences venture capital firm | United States |
(1 Apr 2008)
Investor | Profile | Country | Notes | |
---|---|---|---|---|
OrbiMed Advisors LLC | American investment firm focused on making public and private investments in the healthcare and biotechnology industries. | United States |
Cap Table
Current and past shareholders
Investor | Contacts | Round | |
---|---|---|---|
Clarus Ventures LLC Life sciences venture capital firm |
+1 (617) 949-2200 |
N/A | |
OrbiMed Advisors LLC American investment firm focused on making public and private investments in the healthcare and biotechnology industries. |
+1 (212) 739-6400 |
N/A | |
Otsuka Pharmaceutical |
Acquisition | ||
Oxford Finance LLC Provider of capital exclusively to life sciences and healthcare services companies worldwide. |
Debt | ||
ProQuest Investments |
+1 (858) 847-0315 |
N/A | |
Silicon Valley Bank |
Debt | ||
Vivo Ventures LLC |
+1 (650) 688-0818 |
N/A |